- Home
- EHTH vs ADAG Comparison
EHTH vs ADAG Comparison
Compare EHTH & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ADAG
- Stock Information
- Founded
- EHTH 1997
- ADAG 2011
- Country
- EHTH United States
- ADAG China
- Employees
- EHTH N/A
- ADAG N/A
- Industry
- EHTH Specialty Insurers
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- ADAG Health Care
- Exchange
- EHTH Nasdaq
- ADAG Nasdaq
- Market Cap
- EHTH 105.1M
- ADAG 110.8M
- IPO Year
- EHTH 2006
- ADAG 2021
- Fundamental
- Price
- EHTH $3.91
- ADAG $2.32
- Analyst Decision
- EHTH Buy
- ADAG Strong Buy
- Analyst Count
- EHTH 4
- ADAG 2
- Target Price
- EHTH $8.50
- ADAG $7.00
- AVG Volume (30 Days)
- EHTH 297.7K
- ADAG 111.5K
- Earning Date
- EHTH 11-05-2025
- ADAG 08-12-2025
- Dividend Yield
- EHTH N/A
- ADAG N/A
- EPS Growth
- EHTH N/A
- ADAG N/A
- EPS
- EHTH N/A
- ADAG N/A
- Revenue
- EHTH $547,491,000.00
- ADAG $103,204.00
- Revenue This Year
- EHTH $4.99
- ADAG $9,789.15
- Revenue Next Year
- EHTH $3.41
- ADAG $29.92
- P/E Ratio
- EHTH N/A
- ADAG N/A
- Revenue Growth
- EHTH 16.19
- ADAG N/A
- 52 Week Low
- EHTH $3.18
- ADAG $1.33
- 52 Week High
- EHTH $11.36
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- EHTH 52.47
- ADAG 57.48
- Support Level
- EHTH $3.87
- ADAG $2.11
- Resistance Level
- EHTH $4.17
- ADAG $2.45
- Average True Range (ATR)
- EHTH 0.20
- ADAG 0.19
- MACD
- EHTH 0.04
- ADAG 0.00
- Stochastic Oscillator
- EHTH 65.79
- ADAG 62.15
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.